Fundz

Neion Bio, a NYC-based biomanufacturing company, raised approximately $11M in funding led by Caffeinated Capital with participation from others.

PRIVATEMar 27, 2026

Amount Raised

$11 Million

Round Type

Seed

ManufacturingBiotechnology

Investors

Basis Set VenturesHaystack VCCaffeinated Capital

Description

Neion Bio has emerged from stealth with about $11 million raised to date in financing. The company is focused on advancing biologic medicines through innovative biomanufacturing techniques. Neion Bio also signed its first co-development agreement with a global pharmaceutical company, providing them with near-term revenue. Their platform aims to strengthen domestic manufacturing capabilities for critical medicines.

Quick answer

Neion Bio raised $11 Million in a Seed round, dated March 27, 2026. Investors: Basis Set Ventures, Haystack VC and Caffeinated Capital.

How much did Neion Bio raise?
Neion Bio raised $11 Million in a Seed round on March 27, 2026.
Who invested in Neion Bio?
Basis Set Ventures, Haystack VC and Caffeinated Capital are named as investors in this round.
What does Neion Bio do?
Neion Bio is a NYC-based biotechnology company advancing biologic medicines.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Neion Bio that raised within 45 days of this round, from Fundz verified event records.

  • CellCentric raised $220M (Series D) on May 6, 2026.
  • MilkyMist raised $51M on May 4, 2026.
  • Loliware raised $3M (Seed) on May 4, 2026.
  • Lucid Group raised $550M (Series C) on May 1, 2026.
  • Red Light Holland raised $997K on April 29, 2026.
  • Liquid Instruments raised $50M (Series C) on April 28, 2026.

Who to call at Neion Bio, and when

A new round usually means Neion Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neion Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neion Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neion Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neion Bio

About

Neion Bio is a NYC-based biotechnology company advancing biologic medicines. Launched in 2024, it utilizes frontier genetic engineering to harness eggs for the production of biological medicines. Their Raptor™ platform enables localized, resilient domestic manufacturing of critical medicines, bolstering national security and presenting significant commercial opportunities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neion Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neion Bio's next move

See what Strategic adds

Neion Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.